Kidney Cancer Patient Forum
Register to appear on the Support Network map or join the Forum.
TIVOZANIB - phase 3 trial
1 post • Page 1 of 1
TIVOZANIB - phase 3 trial
by Rose Woodward on Thu Jul 15, 2010 9:32 pm
Aveo Pharmaceuticals Inc. (AVEO) :The company's lead product, tivozanib, is an oral, triple VEGF receptor inhibitor with potential for a best-in-class profile. Tivozanib is currently being investigated in a global, randomized Phase 3 clinical trial called TIVO-1 comparing tivozanib to sorafenib in advanced kidney cancer, as well as additional clinical studies in other solid tumor types
- Rose Woodward
- Posts: 271
- Joined: Mon Dec 01, 2008 1:31 am
- Location: Porthtowan. Nr Truro Cornwall
- Region: Cornwall and Isles of Scilly
- Appear on map: yes
- First part of postcode: TR4
- Your status: KC Survivor
- Gender: Female
1 post • Page 1 of 1